Syra Health Corp. Class A Common Stock
SYRA
SYRA was delisted on the 17th of April, 2025.
9 hedge funds and large institutions have $43.8K invested in Syra Health Corp. Class A Common Stock in 2025 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 6 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
31% less funds holding
Funds holding: 13 → 9 (-4)
67% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 6
81% less capital invested
Capital invested by funds: $228K → $43.8K (-$184K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$19K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$7.53K |
| 3 |
Citigroup
New York
|
+$251 |
| 4 |
Barclays
London,
United Kingdom
|
+$97 |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$5 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCC
Cable Car Capital
San Francisco,
California
|
-$106K |
| 2 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
-$41.1K |
| 3 |
VF
Virtu Financial
New York
|
-$14K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$9.67K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$9.52K |
SYRA Hedge Fund Activity: Q1 2025 in Review
9 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in Syra Health Corp. Class A Common Stock (SYRA) for Q1 2025, worth a combined $43.8K — down 81% from $228K a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of SYRA and 2 opened new positions — a net loss of 4 holders — while 2 trimmed existing stakes and 3 added.
The largest buyer was Geode Capital Management, adding an estimated $19K. The largest seller was Cable Car Capital, exiting entirely with an estimated $106K sold.
- 9 institutional investors held Syra Health Corp. Class A Common Stock (SYRA) as of Q1 2025, down from 13 in Q4 2024.
- Funds reported $43.8K of Syra Health Corp. Class A Common Stock stock for Q1 2025, down 81% quarter-over-quarter.
- 2 funds opened new Syra Health Corp. Class A Common Stock positions in Q1 2025 and 6 closed out, a net change of -4 holders.
- The largest Syra Health Corp. Class A Common Stock buyer in Q1 2025 was Geode Capital Management, an estimated $19K added.
- The largest Syra Health Corp. Class A Common Stock seller in Q1 2025 was Cable Car Capital, an estimated $106K sold.
Based on aggregated 13F filings for Q1 2025.